Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7355 USD | +0.07% |
|
-4.38% | -34.33% |
05-20 | Bolt Biotherapeutics, Inc. Announces Management Changes | CI |
05-20 | Bolt Biotherapeutics, Inc. Announces Chief Executive Officer Changes | CI |
Business Summary
Number of employees: 100
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Immunotherapies
100.0
%
| 6 | 100.0 % | 8 | 100.0 % | +37.48% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 8 | 100.0 % | +37.48% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Quinn
CEO | Chief Executive Officer | 53 | 20-04-30 |
John Tomaro
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Priti Hegde
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Grant Yonehiro
COO | Chief Operating Officer | 60 | 16-10-31 |
Karen L. Bergman
IRC | Investor Relations Contact | - | - |
Sarah Nemec
AUD | Comptroller/Controller/Auditor | 48 | 20-07-31 |
Yu Tai
LAW | General Counsel | - | - |
Wesley Burwell
HRO | Human Resources Officer | - | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 16-08-31 |
James Healy
BRD | Director/Board Member | 59 | 20-12-31 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 20-11-30 |
Nicole Onetto
BRD | Director/Board Member | 71 | 21-12-13 |
Director/Board Member | 54 | 21-11-16 | |
Frank Lee
BRD | Director/Board Member | 56 | 21-11-16 |
Laura Berner
BRD | Director/Board Member | 49 | 22-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,127,740 | 36,804,957 ( 96.53 %) | 0 | 96.53 % |
Company contact information
Bolt Biotherapeutics, Inc.
900 Chesapeake Drive
94063, Redwood City
+650 665 9295
http://www.boltbio.com![address Bolt Biotherapeutics, Inc.(BOLT)](https://cdn.zonebourse.com/static/address/118683093.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.33% | 28.04M | |
+15.85% | 122B | |
+18.91% | 113B | |
+4.43% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-16.61% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- BOLT Stock
- Company Bolt Biotherapeutics, Inc.